The World's Most Flexible Jurisdiction for Health & Biotech
Próspera is revolutionizing regulatory frameworks, enabling Health and Biotech companies to bring innovations to market 10-100x faster than traditional jurisdictions.
Business Advantages
Why Health Companies Choose Próspera
Próspera injects market mechanisms into the regulatory system, creating unprecedented flexibility and efficiency for health and biotech innovators.
Accelerated Market Entry
Go to market 10-100x faster than in traditional jurisdictions through our flexible insurance-based regulatory framework.
Flexible Regulatory Framework
Choose from standard OECD country regulations, established best practices, or propose your own custom regulatory framework.
Cost Efficiency
Dramatically reduce regulatory costs from an average of $300MM to approximately $300K through our streamlined processes.
Insurance-Based Compliance
Replace complex agency approvals with a simple insurance policy, saving time while maintaining safety standards.
Cost Comparison
Dramatically Lower Market Entry Costs
Traditional regulatory frameworks like the FDA can cost companies an average of $300MM to bring new health innovations to market. In contrast, Próspera's approach reduces this to approximately $300K.
The Process
Regulation via Insurance
Regulation, but smarter. Insurers, not bureaucrats, set the standards. Businesses get oversight that's fast, accountable, and built for innovation.
Próspera's Approach
Insurance-based regulatory system
Choose Your Own Set of Laws
Choose between:
- Existing OECD country regulations (Sweden, Delaware, France, etc...)
- Common Law (with 3x damages)
- Adopt any current best practice regulations only available in Próspera, OR propose a new framework of your own.
Gain Insurance Coverage
Instead of traditional regulatory approval, secure an insurance policy from an insurer who accepts your chosen regulatory framework.
Launch Your Innovation
With insurance in place, you're free to commercialize your healthcare or biotech product in Próspera, bringing it to market in a fraction of the time.
Market Success in Months, Not Years
With dramatically lower costs.
Traditional Approach
Monopoly regulator based system
Apply to FDA/EMA
Submit applications to FDA, EMA or other governmental regulatory bodies that have monopoly power over medical product approvals.
Complete Phase 2 & 3 Clinical Trials
Conduct expensive and time-consuming clinical trials with hundreds or thousands of patients.
Timeline: 3-7+ years
High Costs & Uncertain Approval
Invest hundreds of millions in testing with no guarantee of final approval.
Cost: $50M-$2B+ before commercialization is possible.
Years of Delay
With enormous costs and regulatory uncertainty.
Companies are required to have a compliance offer and will be subject to periodic audits
Companies in the Próspera Ecosystem
Innovative health and biotech companies are already leveraging Próspera's flexible regulatory framework to advance medical science.
Infinita
Building a longevity district focused on accelerating biotech & longevity research.
Garm Clinic
Established leader in Regenerative & longevity medicine for 11+ years. Offering CRO services to help incubate young innovative companies.
Gene Therapy
Minicircle is offering the world's most advanced reversible gene therapy exclusively in Prospera. Bryan Johnson traveled down to take it. Unlimited Bio is also offering gene therapy.
World-class companies are building the future of healthcare and longevity in Próspera's regulatory environment, unlocking innovations that can't be developed elsewhere.
Regulatory Framework
Choose Your Regulatory Approach
Choose between: 1. Existing OECD country regulations (Sweden, Delaware, France, etc.) 2. Adopt any current best practice regulations only available in Próspera 3. Propose a new framework of your own
Standard OECD Country Regulations
Select a regulatory framework from an established OECD country that best suits your innovation. These frameworks have proven track records of balancing innovation and safety.
Popular OECD Frameworks
FDA (USA)
EMA (European Union)
PMDA (Japan)
Health Canada
Benefits
Familiar to global investors and partners
Recognized international standards
Well-documented implementation pathways
Whichever pathway you choose, our innovative regulatory approach minimizes bureaucracy while maximizing safety through market-based mechanisms and transparency.
Ready to Revolutionize Your Path to Market?
Join innovative health and biotech companies already leveraging Próspera's flexible regulatory framework to bring their innovations to market faster and at a fraction of the cost.
